Table 3.
No. | Baseline
|
Lesions size at baseline
|
Total scores | Last follow-up
|
Lesions size at last follow-up
|
Total scores | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
atrophy | depigmentation | hyperkeratosis | sclerosis | < 30% | 30–60% | > 60% | atrophy | depigmentation | hyperkeratosis | sclerosis | < 30% | 30–60% | > 60% | |||
1 | 2 | 3 | 1 | 1 | 0 | 0 | 1.5 | 8.5 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 4 |
2 | 2 | 3 | 2 | 2 | 0 | 0 | 1.5 | 10.5 | 1 | 2 | 0 | 1 | 0 | 1 | 0 | 5 |
3 | 2 | 3 | 0 | 0 | 0 | 0 | 1.5 | 6.5 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 2 |
4 | 2 | 3 | 1 | 1 | 0 | 0 | 1.5 | 8.5 | 1 | 2 | 0 | 1 | 0.5 | 0 | 0 | 4.5 |
5 | 3 | 3 | 2 | 0 | 0 | 0 | 1.5 | 9.5 | 1 | 2 | 0 | 0 | 0.5 | 0 | 0 | 3.5 |
6 | 2 | 3 | 2 | 2 | 0 | 0 | 1.5 | 10.5 | 0 | 1 | 0 | 1 | 0.5 | 0 | 0 | 2.5 |
7 | 2 | 3 | 0 | 0 | 0 | 1 | 0 | 6 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0.5 |
8 | 2 | 3 | 1 | 0 | 0 | 1 | 0 | 7 | 1 | 1 | 0 | 0 | 0.5 | 0 | 0 | 2.5 |
9 | 2 | 3 | 2 | 2 | 0 | 0 | 1.5 | 10.5 | 1 | 1 | 0 | 1 | 0.5 | 0 | 0 | 3.5 |
10 | 2 | 3 | 0 | 0 | 0 | 1 | 0 | 6 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0.5 |
Mean | 2.1 | 3 | 1.1 | 0.8 | 0 | 0.3 | 1.05 | 8.35 | 0.6 | 1.1 | 0 | 0.5 | 0.35 | 0.3 | 0 | 2.85 |